Literature DB >> 7310464

The sequential development of nodal sprouts in mouse muscles in response to nerve degeneration.

W G Hopkins, J R Slack.   

Abstract

Nodal sprouting in response to axonal degeneration was studied in silver-stained, wholemount preparations of the thin, sheet-like mouse muscles tensor faciae latae (TFL) and the inferior and superior gluteus maximus. Axon degeneration in TFL and gluteus was produced by cutting the L14 spinal nerve (partial denervation). Axon degeneration in the gluteus was also produced by superior gluteal and TFL nerve section (hemidenervation). Two days after partial or hemidenervation motor nerve nodal sprouts begin to appear in the intramuscular nerves. Sprout growth is rapid, since only a small percentage of sprouts are ever seen not to terminate at endplates. Sprouts continue to appear for at least three weeks after partial denervation, when there are up to five times as many endplates innervated by sprouts as by remaining intact axons. Sprouts arise at nodes near the denervated endplates, which they innervate by growing directly down the degenerating nerve. Sprout initiation proceeds sequentially in partly and hemidenervated muscles, since the average length of sprouts contacting endplates increases with time. Analysis of silver-stained muscles by combined light and electron microscopy shows that this sequential development is unlikely to be a consequence of slow growth and maturation of submicroscopic sprouts initiated nonsequentially throughout the intramuscular nerves. The observations are consistent with a nodal sprouting mechanism which requires a cellular or structural change in the denervated Schwann cell pathway to spread disto-proximally from the terminal ends of the nerves and thereby to permit the growth of nodal sprouts. The initiation of sprout growth may require a diffusible substance from degenerating nerve or denervated muscle.

Entities:  

Mesh:

Year:  1981        PMID: 7310464     DOI: 10.1007/bf01262589

Source DB:  PubMed          Journal:  J Neurocytol        ISSN: 0300-4864


  9 in total

1.  Peripheral nerve regeneration through optic nerve grafts.

Authors:  P N Anderson; P Woodham; M Turmaine
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

2.  When motor unit expansion in ageing muscle fails, atrophy ensues.

Authors:  Russell T Hepple
Journal:  J Physiol       Date:  2018-04-06       Impact factor: 5.182

3.  A method for visualizing axons and endplates throughout whole mounts of skeletal muscles using combined silver and cholinesterase stain.

Authors:  J R Slack; S Pockett
Journal:  Pflugers Arch       Date:  1981-10       Impact factor: 3.657

4.  Abnormal response of distal Schwann cells to denervation in a mouse model of motor neuron disease.

Authors:  Dario I Carrasco; Ben A Bahr; Kevin L Seburn; Martin J Pinter
Journal:  Exp Neurol       Date:  2016-02-04       Impact factor: 5.330

Review 5.  Target Receptors of Regenerating Nerves: Neuroma Formation and Current Treatment Options.

Authors:  Feras Shamoun; Valentina Shamoun; Arya Akhavan; Sami H Tuffaha
Journal:  Front Mol Neurosci       Date:  2022-07-05       Impact factor: 6.261

6.  Short- and long-term effects of paralysis on the motor innervation of two different neonatal mouse muscles.

Authors:  M C Brown; W G Hopkins; R J Keynes
Journal:  J Physiol       Date:  1982-08       Impact factor: 5.182

Review 7.  Selective peripheral neurotomy (SPN) for spasticity in childhood.

Authors:  M P Sindou; F Simon; P Mertens; P Decq
Journal:  Childs Nerv Syst       Date:  2007-06-29       Impact factor: 1.475

8.  Suppression of terminal axonal sprouting at the neuromuscular junction by monoclonal antibodies against a muscle-derived antigen of 56,000 daltons.

Authors:  M E Gurney; B R Apatoff; S P Heinrich
Journal:  J Cell Biol       Date:  1986-06       Impact factor: 10.539

9.  Nerve sprouting in innervated adult skeletal muscle induced by exposure to elevated levels of insulin-like growth factors.

Authors:  P Caroni; P Grandes
Journal:  J Cell Biol       Date:  1990-04       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.